Protyon

Groningen, The Netherlands

Protyon provides an analysis service examines the effect of mutations in specific proteins targeted for treatment in lung cancer.

$655K raised

May 2023

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Protyon raised?

Protyon has raised $655K in total funding. The most recent round was Pre-Seed. The last funding was announced in May 2023.

Who are Protyon's investors?

Protyon's investors include LUMO labs, NV NOM.

Where is Protyon headquartered?

Protyon is headquartered in Groningen, The Netherlands.

What does Protyon do?

Protyon provides an analysis service examines the effect of mutations in specific proteins targeted for treatment in lung cancer.

What stage is Protyon at?

Protyon is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 11, 2023.

MLA

"Protyon — Funding & Investors." VCBacked, May 11, 2023, https://www.vcbacked.co/company/protyon. Accessed July 2, 2026.

APA

VCBacked. (2023). Protyon — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/protyon

Wikipedia (cite web)

{{cite web |title=Protyon — Funding & Investors |url=https://www.vcbacked.co/company/protyon |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 11, 2023.